0000876661-17-000010.txt : 20170104
0000876661-17-000010.hdr.sgml : 20170104
20170104160323
ACCESSION NUMBER: 0000876661-17-000010
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
EFFECTIVENESS DATE: 20170104
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ST JUDE MEDICAL INC
CENTRAL INDEX KEY: 0000203077
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411276891
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12441
FILM NUMBER: 17505290
BUSINESS ADDRESS:
STREET 1: ONE ST JUDE MEDICAL DRIVE
CITY: ST PAUL
STATE: MN
ZIP: 55117
BUSINESS PHONE: 6517562000
MAIL ADDRESS:
STREET 1: ONE ST JUDE MEDICAL DRIVE
CITY: ST PAUL
STATE: MN
ZIP: 55117
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
203077
ST JUDE MEDICAL INC
001-12441
One St. Jude Medical Drive
St Paul
MN
MINNESOTA
55117-9983
(651) 756-2000
Common Stock
17 CFR 240.12d2-2(a)(3)
Benjamin Sawyer
Manager
2017-01-04
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on January 17, 2017, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on January 4, 2017 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
The merger between St. Jude Medical, Inc. and Abbott Laboratories became effective on January 4, 2017. Each share of St. Jude Medical, Inc. common stock will be converted into 0.8708 shares of Abbott Laboratories common stock and $46.75 in cash, without interest.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading after market close on January 4, 2017.